Marianne T. Armstrong
Chief Tech/Sci/R&D Officer at INTERMUNE INC
Profile
Marianne T.
Armstrong is a professional with a doctorate and graduate degree from Florida State University.
She worked as the Chief Medical Affairs & Regulatory Officer at InterMune, Inc. since 2011.
Prior to that, she was a Senior Director-Clinical Development at Genentech, Inc. from 1999 to 2002, a Senior Director-Clinical Development at PathoGenesis Corp from 1998 to 1999, and the Department Head-Clinical Affairs at Amgen, Inc. from 1995 to 1998.
Marianne T. Armstrong active positions
| Companies | Position | Start |
|---|---|---|
| INTERMUNE INC | Chief Tech/Sci/R&D Officer | 2002-03-31 |
Former positions of Marianne T. Armstrong
| Companies | Position | End |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2002-03-31 |
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Chief Tech/Sci/R&D Officer | 1999-10-31 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | 1998-06-30 |
Training of Marianne T. Armstrong
| Florida State University | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AMGEN INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a private company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Marianne T. Armstrong
